Hydrochlorothiazide/Propranolol hydrochloride

氢氯噻嗪/盐酸普萘洛尔

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHydrochlorothiazide/Propranolol hydrochloride
Drug Alias Name盐酸普萘洛尔/氢氯噻嗪hydrochlorothiazide and propranolol hydrochlorideandpropranolol hydrochlorideand hydrochlorothiazidePropranolol hydrochloride - hydrochlorothiazidePropranolol hydrochloride/Hydrochlorothiazide +[7] 
ClassificationSmall molecules
Mechanisms of ActionBeta adrenergic receptors antagonistsThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterBeta adrenergic receptors
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1979/06/15
Country/TerritoryUnited States
CombinationsYes HydrochlorothiazidePropranolol hydrochloride
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC07BA05
Related LinksKEGG